updates on tafasitamab for the treatment of dlbcl
Published 2 years ago • 370 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:17
the latest updates on tafasitamab in dlbcl
-
1:30
the role of tafasitamab in the lymphoma treatment landscape & promising results from clinical trials
-
2:21
impact of tmtv on pfs following glofitamab treatment in r/r dlbcl
-
2:20
best practices when using tagraxofusp for the treatment of bpdcn
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
29:38
dlbcl treatment approaches: what you need to know
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:03
how bad is lymphoma cancer?
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:25
the current approach to managing patients with prefibrotic pmf
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:02
the changing standard of care in dlbcl
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
1:19
the potential of caplacizumab in the treatment of attp
-
0:42
targeted therapies for dlbcl treatment
-
0:43
the future of ctcl therapy
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
0:53
evolution of the treatment landscape for patients with cns lymphoma
-
1:56
safety and efficacy of plamotamab in the treatment of non-hodgkin lymphoma subtypes
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml